Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Diego
This trial is designed to find the maximum tolerated dose of radiation under a fixed 5-fraction SBRT regimen escalating the dose from 40 Gy in 5 fractions, to 60 Gy in 5 fractions, at 5 Gy intervals.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis: Histologically-proven invasive adenocarcinoma of the pancreas.
Tumor Location: Primary tumor may be located anywhere in the pancreas.
Treatment eligibility: The patient must be able to have fiducial markers implanted into the pancreatic tumor, and receive radiation regimen as specified in the protocol.
Performance Level: Karnofsky Performance Status ≥ 60
Adequate Renal Function Defined As: Serum creatinine ≤ 1.5 x upper limit of normal
Informed Consent: All subjects must sign a written informed consent.
You may not be if
Pregnancy or Breast-Feeding: Pregnant or breast-feeding women will not be entered on this study due to risks of fetal and teratogenic adverse events. (Note: Serum Pregnancy tests must be obtained in women of child bearing potential). Sexually active females may not participate unless they have agreed to use an effective contraceptive method (such as abstinence, diaphragm, condom, or intrauterine device) to prevent pregnancy for the duration of the study.
Life expectancy \< 6 months
The patient cannot have had prior radiation therapy to the thorax or upper abdomen.
